Category: Medical

Upper GI Bleed (UGIB)

Not normally difficult to spot, but look for it in unexplained anaemia, or collapse.

Questions

  • Is it VARICEAL? Mortality 35%, so is an emergency whatever the GBS is.
  • Non-Variceal what’s the GBS? will help guide treatment

Anyone being admitted should be brought to HRI

Emergency Endoscopy is arranged by Med Reg

Read more

LVAD – Resus & Troubleshooting

LVADs (Left Ventricular Assist Device) are becoming more common and there are patients in our region with them as a bridge to transplant or recovery and in some cases a destination therapy.

The patient and their family will likely know more about this device than you and should have brought spare parts. Our local LVAD centre is Wythenshaw however, there are other units around the country the patient may direct you to.

The patient may not have a palpable pulse, the blood pressure will be low and the heart pump sounds like a buzz when you listen.

If patient is unresponsive or has a history of collapse its important to troubleshoot the device and resusitation may be required

Read more

COPD – exacerbations

COPD patients vary widely, due to their comorbidities, social circumstances, and wishes. So choosing the best treatment pathway for the patient can be complex. Involve senior decision makers.

Questions

  • Is hospital the best place for them?
  • Do they need NIV?
  • Are they dying? – would you want to die surrounded by strangers or with your family?

Read more

Time Critical Medications

Time Critical Medication (TCM) is scheduled medication that the patient is already on when they present to the Emergency Department (ED).

The medications are “time critical” because a
delayed or missed dose can result in harm with exacerbation of symptoms and the development of complications leading to an increased mortality.

Movement disorders – Parkinson’s / Myasthenia medication
Immunomodulators including HIV medication
Sugar (Insulin)
Steroids – Addison’s and adrenal insufficiency
Epilepsy – anticonvulsants
DOACs and warfarin

Its really important for our patients that these medications are prescribed and given while in ED/uSDEC/fSDEC.

If you are withholding these medication (which may be necessary) -please document the reason for this clearly in the notes.

In hours speak to pharmacy if you require any support with these patients.

Atrial Fibrillation/Flutter (ECS 2024)

Before you start 

  • Whats the cause? – treating the precipitant often sorts the AF (adding B-Blockers to Sepsis can make things worse)
  • Stable or Unstable?  – Electricity vs. Drugs
  • Rate/Rhythm control
  • CHADS-VASC vs. ORBIT– Anticoagulation
  • NEW Symptomatic Arrhythmia Clinic [6-8weeks] referral form attached tho the PDF

Discharge? – If all of following

    • No compromise
    • HR<110 for 2hr
    • No precipitants requiring admission

AF/SVT Clinic – AF/SVT clinic Referral form

  • This clinic is only for:
    • Symptomatic patients with new onset AF /SVT (where the presenting symptoms are definitely due to AF /SVT)
    • And patients have fast ventricular rates.
    • ECG shows AF/SVT

Unstable AF

Haemodynamically UNSTABLE patients

Any of:

    • Shock sBP <90mmHg – poor perfusion
    • Reduced level of consciousness – poor brain perfusion
    • Cardiac Ischaemia – poor heart perfusion
    • Pulmonary Oedema – poor lung perfusion

Emergency DC Cardioversion (DCC) is the mainstay of treatment. Obviously DCC is uncomfortable experience and sedation is preferable, however, if unstable sedation may not be an option.

DC Cardioversion (SYNCRONISED)

    • Consent (best interest if needed)
    • Sedation if possible (may require anaesthetic assistance)
    • DC Cardiaversion
      1. Syncronise (white dots appear over QRS on monitor)
      2. Energy 
        • 1st shock 70J
        • 2nd shock 120J
        • 3rd shock 200J
      3. Charge & Shock (oxygen away, everyone clear!)
      4. Reassess – repeat for further shocks if required

Tachycardia Guide line – Resus Council

Causes/Tests

Causes

It’s essential any Modifiable causes are treated, these include:

    • Haemodynamic stress: Valvular disease/Hypertension/LVD/Thrombus
    • Atrial ischemia: Ischaemic Heart Disease
    • Inflammation: Sepsis/Myocarditis/pericarditis
    • Noncardiovascular respiratory causes: PE/Pneumonia/Lung Cancer
    • Alcohol and drug use: Alcohol/Cocaine/Amphetamine
    • Endocrine disorders: Hyperthyroid/Diabetes/Phaeochromacytoma/Electrolyte prob.
    • Neurologic disorders: Subarachnoid Haemorrhage/Stroke
    • Genetic factors
    • Advancing age

Tests (NEW AF)

  • 12 Lead ECG
  • Bloods: FBC, U&E, Bone profile, Magnesium, LFT, TFT, Clotting, Glucose
  • Others: individualised to the patient.
STABLE – Rate/Rhythm Control

Rate Control

  • First line:
    • β-Blocker – outperforms calcium channel blockers in studies
    • Non-dihydropyridine calcium channel blockers (Diltiazem/Verapamil) – esp. in Severe COPD/Asthma
  • Second Line:Consider adding in
    • Digoxin – however, digoxin alone is not effective in patients with increased sympathetic drive. Observational studies have associated digoxin use with excess mortality in AF patients)
    • Amiodarone can be useful as a last resort when heart rate cannot be controlled with combination therapy in patients who do not qualify for non-pharmacological rate control

Rhythm control in ED

“Early cardioversion is not recommended without appropriate anticoagulation or transoesophageal echocardiography if AF duration is longer than 24 h, or there is scope to wait for spontaneous cardioversion.”

In reality risks increase beyond 12hrs from onset, and those reverted in ED will often return to AF by the time they get to AF clinic follow up.

STABLE – Stroke Prevention

Anticoagulation

AF increases the chance of Stroke by 5x (and those recently diagnosed are least likely be on any form of protection)

  • ESC/NICE recommends using the CHADS-VASc to assess stroke risk and ORBIT to assess bleeding risk
  • There are currently significant delays getting to “New AF” clinic as well as to GP’s, making assessment of Stroke risk in ED more important than ever

CHADS-VASc outcome recommendations

    • Males (0), Female (1) – No anticoagulation recommended
    • Males (1) – Consider anticoagulation (DOAC) in light of bleed risk
    • ALL (≥2) – Anticoagulation recommended (DOAC)- Trust DOAC guide,  NICE/CKS
    • Use Apixaban where first line, significantly cheaper. If using alternative please document reasons.

ORBIT outcome recommendations

    • Modifiable risks – Address ALL modifiable risk factors
    • Most will benefit from anticoagulation – but discuss personalised risk with patients

Contraindications to Anticoagulation inc:

    • Active serious bleeding (where the source should be identified and treated)
    • Associated comorbidities (e.g. severe thrombocytopenia <50 platelets/lL, severe anaemia under investigation, etc.)
    • Recent high-risk bleeding event such as intracranial haemorrhage (ICH).

 

STABLE – Comorbidities

Cardiovascular risk factors

    • Life Style
      • Obesity: Risk of AF, Recurrence of AF and Stoke all increase with BMI
      • Alcohol: Alcohol excess both increases the risk of AF and of Bleeding, so patient should support to reduce aldol intake is recommended
      • Caffeine: It is unlikely caffeine consumption causes AF. Habitual caffeine use may reduce the risk of developing AF. But increases the symptoms
      • Exercise: Moderate cardiavasclar exercise is protective, however higher rates of AF are seen in elite athletes and vigorous physical activity
    • Specific conditions- patient should follow up with GP/Clinic (treatment may start in ED)
      • Hypertension
      • Heart Failure
      • Coronary artery disease
      • Diabetes Mellitus
      • Sleep Apnoea
STABLE – CARE